Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Aug;57(2):110-5.
doi: 10.1016/j.jinf.2008.04.003. Epub 2008 Jun 3.

Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections

Julia C Dombrowski  1 , Lisa G Winston
Affiliations

Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections

Julia C Dombrowski et al. J Infect. 2008 Aug.

Abstract

Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) infections can be difficult to treat. We evaluated the rate of clinical failure in appropriately-treated patients and determined risk factors for failure.

Methods: We retrospectively studied a cohort of patients with invasive MRSA infections who completed recommended therapy at one hospital over a 7 year period.

Results: Two-hundred and fifteen cases were included. Vancomycin monotherapy was given in 73%. Failure rates by infection site were as follows: osteomyelitis 37/81 (46%), epidural abscess five/18 (28%), surgical wound four/15 (27%), pneumonia eight/45 (18%), endocarditis five/32 (16%), bloodstream five/42 (12%), joint one/23 (4%), and meningitis zero/one (0%). In multivariate analysis, only a diagnosis of osteomyelitis was independently associated with relapse (p<0.001).

Conclusions: We found a high rate of treatment failure in an urban population among patients who completed recommended therapy, largely with vancomycin alone. Failure in osteomyelitis was particularly common. High quality comparative studies of antibiotic regimens for MRSA infections, particularly osteomyelitis, are needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow Diagram of Case Selection
See this image and copyright information in PMC

References

    1. Stevens DL. The role of vancomycin in the treatment paradigm. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S51–S57. - PubMed
    1. Liu C, Chambers HF. Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrobial agents and chemotherapy. 2003 Oct;47(10):3040–3045. - PMC - PubMed
    1. Tice AD, Hoaglund PA, Shoultz DA. Risk factors and treatment outcomes in osteomyelitis. The Journal of antimicrobial chemotherapy. 2003 May;51(5):1261–1268. - PubMed
    1. Chang FY, Peacock JE, Jr., Musher DM, Triplett P, MacDonald BB, Mylotte JM, et al. Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine. 2003 Sep;82(5):333–339. - PubMed
    1. Siegman-Igra Y, Reich P, Orni-Wasserlauf R, Schwartz D, Giladi M. The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia. Scandinavian journal of infectious diseases. 2005;37(8):572–578. - PubMed

Publication types